1. Home
  2. SLNH vs TXMD Comparison

SLNH vs TXMD Comparison

Compare SLNH & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soluna Holdings Inc.

SLNH

Soluna Holdings Inc.

HOLD

Current Price

$1.43

Market Cap

174.8M

Sector

Technology

ML Signal

HOLD

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$1.69

Market Cap

21.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNH
TXMD
Founded
1961
2008
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
174.8M
21.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SLNH
TXMD
Price
$1.43
$1.69
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
5.0M
126.7K
Earning Date
11-17-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$28,782,000.00
$2,796,000.00
Revenue This Year
N/A
$427.09
Revenue Next Year
$42.68
N/A
P/E Ratio
N/A
$277.12
Revenue Growth
N/A
75.19
52 Week Low
$0.36
$0.70
52 Week High
$5.14
$2.44

Technical Indicators

Market Signals
Indicator
SLNH
TXMD
Relative Strength Index (RSI) 39.93 53.89
Support Level $1.78 $1.46
Resistance Level $2.29 $2.01
Average True Range (ATR) 0.26 0.17
MACD 0.04 -0.01
Stochastic Oscillator 2.87 47.41

Price Performance

Historical Comparison
SLNH
TXMD

About SLNH Soluna Holdings Inc.

Soluna Holdings Inc is a U.S.-based company that conducts operations through its subsidiary. The group is engaged in the mining of cryptocurrency through data centers that can be powered by renewable energy sources. The data centers buy every excess megawatt to use for batch-oriented, computing-intensive processes such as cryptocurrency mining or machine learning which is a low-risk and low-friction solution to use as a smartphone.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: